Pulse Oximetry

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

GH
2 programs
Pulse oximetryN/A1 trial
SpO2 Sensor application & blood drawN/A1 trial
Active Trials
NCT01613222Completed63Est. Feb 2013
NCT03383757Completed117Est. Nov 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GE HealthCareSpO2 Sensor application & blood draw
GE HealthCarePulse oximetry

Clinical Trials (2)

Total enrollment: 180 patients across 2 trials

NCT03383757GE HealthCareSpO2 Sensor application & blood draw

U-TruSignal SpO2 Testing in Neonates

Start: Sep 2017Est. completion: Nov 2019117 patients
N/ACompleted

SpO2 System Accuracy Testing With Different Sensors

Start: Jun 2012Est. completion: Feb 201363 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space